• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Liver international >Screen‐detected gallstone disease and risk of liver and pancreatic cancer: The Kailuan Cohort Study
【24h】

Screen‐detected gallstone disease and risk of liver and pancreatic cancer: The Kailuan Cohort Study

机译：Screen‐detected gallstone disease and risk of liver and pancreatic cancer: The Kailuan Cohort Study

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Abstract Background Few studies have examined the risk of gastrointestinal cancers in screen‐detected gallstone disease. This study aimed to investigate the association between screen‐detected gallstone disease and gastrointestinal cancers using the Kailuan cohort, a population‐based prospective cohort initiated in 2006. Methods A total of 79?809 men who underwent gallbladder ultrasonography, were free of cancers in 2006 and did not have gastrointestinal cancers within one year were enrolled. A Cox proportional hazards model with age as the timescale was used to evaluate the association between screen‐detected gallstone disease and gastrointestinal cancers. Results We identified 1264 cases with gastrointestinal cancers, including 303 cases with liver cancer and 94 cases with pancreatic cancer. Screen‐detected gallstone disease increased the risk of liver cancer, with an HR of 2.28 [95% confidence interval (CI): 1.20‐4.33, P ?=?.012]. The association was modified by the hepatitis B surface antigen status. A non‐significant positive association was observed between pancreatic cancer and gallstone disease (HR 2.19, 95% CI: 0.95‐5.05, P ?=?.065). However, the HR became significant after those individuals with diabetes were excluded (HR 2.60, 95% CI: 1.12‐6.01, P ?=?.026). Conclusion Screen‐detected gallstone disease may predict the risk for liver and pancreatic cancer.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号